Statements of Operations - USD ($)	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 104,203,230	$ 60,594,005
General and administrative	9,063,721	5,636,326
Total operating expenses	113,266,951	66,230,331
Loss from operations	(113,266,951)	(66,230,331)
Other (expense) income
Interest expense	(10,280,445)	(5,326,387)
Interest income	11,768,291	7,777,602
Other income, net	1,487,846	2,451,215
Net loss before income taxes	(111,779,105)	(63,779,116)
Income tax benefits
Net loss	$ (111,779,105)	$ (63,779,116)
Net loss per share, basic	$ (2.83)	$ (2.69)
Net loss per share, diluted	$ (2.83)	$ (2.69)
Weighted average common shares outstanding, basic	39,449,393	23,679,472
Weighted average common shares outstanding, diluted	39,449,393	23,679,472

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.